[HTML][HTML] Epigenetic mechanisms involved in melanoma pathogenesis and chemoresistance

A Martinez-Cardús, M Vizoso, S Moran… - Annals of translational …, 2015 - ncbi.nlm.nih.gov
The discovery of highly recurrent mutations in melanoma, such as BRAF V600E, completely
changed the clinical management including therapy of melanoma patients. In the era of …

MicroRNA-139-5p modulates the growth and metastasis of malignant melanoma cells via the PI3K/AKT signaling pathway by binding to IGF1R

C Yang, Z Xia, L Zhu, Y Li, Z Zheng, J Liang, L Wu - Cell Cycle, 2019 - Taylor & Francis
The relation between microRNAs (miRNAs) and malignant melanoma has been
demonstrated in previous studies, while there was little research about miR-139-5p and …

[HTML][HTML] miR‑186 suppressed CYLD expression and promoted cell proliferation in human melanoma

H Qiu, S Yuan, X Lu - Oncology Letters, 2016 - spandidos-publications.com
Previous studies have shown that microRNA‑186 (miR‑186) is overexpressed in various
human cancers and is associated with the regulation of the carcinogenic processes …

[HTML][HTML] The concept of hormesis in cancer therapy–Is less more?

A Gaya, CA Akle, S Mudan, J Grange - Cureus, 2015 - ncbi.nlm.nih.gov
There has, in recent years, been a paradigm shift in our understanding of the role of the
immune system in the development of cancers. Immune dysregulation, manifesting as …

[HTML][HTML] MicroRNA-342 prohibits proliferation and invasion of melanoma cells by directly targeting zinc-finger E-box-binding Homeobox 1

Q Shi, Q He, J Wei - Oncology Research, 2018 - ncbi.nlm.nih.gov
As documented in numerous studies, microRNAs (miRNAs) play key roles in various
biological processes associated with melanoma occurrence and development. In this study …

Vascular endothelial growth factor/semaphorin-3A ratio and SEMA3A expression in cutaneous malignant melanoma

G Lucarini, O Simonetti, R Lazzarini… - Melanoma …, 2020 - journals.lww.com
Breslow thickness and Clark level are still important factors for cutaneous melanoma, but do
not provide a precise prognosis in all cases. It is necessary to find new factors capable of a …

[HTML][HTML] Molecular signatures associated with tumor-specific immune response in melanoma patients treated with dendritic cell-based immunotherapy

T García-Salum, A Villablanca, F Matthäus, A Tittarelli… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Purpose We previously showed that autologous dendritic cells (DCs) loaded with an
allogeneic heat shock (HS)-conditioned melanoma cell-derived lysate, called TRIMEL …

[HTML][HTML] Dormancy of growth-stunted malignant melanoma: sustainable and smoldering patterns

C Piérard-Franchimont, T Hermanns-Lê… - Oncology …, 2014 - ncbi.nlm.nih.gov
The presentations of primary and metastatic cutaneous malignant melanoma (CMM) are
very diverse. Evidence increasingly indicates that single CMM cells spread to distant sites …

[引用][C] 一种结肠癌干细胞上皮-间质转化分层模型的建立和验证

李鹏, 马晓莹, 李小嘉, 金文琪, 丁旭枫, 郭修田 - 中国癌症杂志, 2019

[引用][C] 308nm 准分子激光治疗白癜风的作用机制

徐可佳, 刁庆春 - 中国麻风皮肤病杂志, 2015